Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 100   

Articles published

NVS 89.84 +0.11 (0.12%)
price chart
Active Stocks: Vodafone Group (NASDAQ:VOD), Novartis (NYSE:NVS), Jacobs ...
Novartis AG (ADR) (NYSE:NVS) [Trend Analysis] reported that it has reached on an exclusive worldwide licensing contract with the worldwide Alliance for TB Drug Development for compounds to fight tuberculosis that have been discovered at the Novartis ...
Novartis Suffers Setback: Judge Rules DoJ Investigation Into Kickbacks To ...
Novartis AG's (ADR) (NVS), attempts to thwart the US Department of Justice's investigations into possible kickbacks to promote the sales of the company's drugs took a hit yesterday.
Related articles »  
China's Raiding the Offices of These Major US Companies � and You Won't Like ...
... (Nasdaq: QCOM), and Delaware-based InterDigital Inc. (Nasdaq: IDCC). Last year, China conducted raids on several Big Pharma companies, including Novartis AG (NYSE ADR: NVS), AstraZeneca Plc. (NYSE ADR: AZN), and Eli Lilly and Co. (NYSE: LLY).
Related articles »  
Drug Manufacturers In News- AbbVie Inc (NYSE:ABBV), Merck & Co., Inc. (NYSE ...
Efforts to develop the initial new malaria treatment in 20 years advanced as a pill from Novartis AG (ADR) (NYSE:NVS) [Trend Analysis] empty parasites earlier than the best medicines, potentially providing a solution to the spread of drug resistance ...
Worth Watching Stocks: Achillion Pharmaceuticals (NASDAQ:ACHN), Talisman ...
Switzerland-based Novartis AG (ADR) (NVS) signed a deal to license its experimental drugs for the treatment of tuberculosis (TB) to the Global Alliance for TB Drug Development (TB Alliance).
Related articles »  
Anacor Continues To Skyrocket: Up 9% In After-Hours Trading
The California-based biopharmaceutical hit the news last month when it announced on July 21, its deal with Novartis AG (ADR)'s (NVS) generic pharmaceuticals division Sandoz to commercialize its antifungal solution Kerydin in the US. Novartis has been ...
Eli Lilly Announces Successful Phase III Results For Psoriasis Drug
On the other hand, AbbVie's blockbuster drug Humira brought in $3.4 billion, or 66.7% of the company's total sales, in the same period.
Related articles »  
Stocks Reaction on News Chiquita Brands International (NYSE:CQB), Kinder ...
Novartis AG's (ADR) (NYSE:NVS) [Trend Analysis] to release results on new first of its type medicine LCZ696 and study met primary end point.
Related articles »  
European ADRs Decline, Led By Mining Companies
Arcelor Mittal ( MT ), the integrated steel and mining company, rose 0.85% and pharmaceuticals company Novartis ( NVS ) jumped 0.67%.
Abnormal Volume Gains- The Home Depot (NYSE:HD), Boston Scientific (NYSE ...
Novartis AG (ADR) (NYSE:NVS) [Trend Analysis] reported that Elbit Medical Technologies, a subsidiary of the firm in which it holds 86% of the voting power, released that on August 18, 2014, Gamida Cell Ltd.
Related articles »